Effects of dapagliflozin on myocardial motion parameters and cardiac electrophysiology in patients with type 2 diabetes Mellitus and coronary heart disease - Poll - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Impact of Dapagliflozin on Cardiac Motion Metrics and Electrophysiological Function in Individuals with Type 2 Diabetes Mellitus and Coronary Artery Disease

  • By

  • Fang Liu

  • Rui Jin

  • June 4, 2026

Share

Original Source(s)

Effects of dapagliflozin on myocardial motion parameters and cardiac electrophysiology in patients with type 2 diabetes Mellitus and coronary heart disease

  • by Fang Liu, Rui Jin

  • June 4, 2026

Related Content

Does Weight Loss Intervention Improve Persistent AF?

Randomized trial found significant weight loss did not improve atrial fibrillation severity or burden in older patients with persistent disease.

Editorial: Emerging technologies in imaging for pediatric heart conditions

Atrial fibrillation burden and oral anticoagulation: a context-dependent framework for net clinical benefit beyond binary AF definitions